Clinical trial
Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression
NCT00188643 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188643 |
|---|---|
| Title | Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression |
| Official title | Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Venlafaxine and Lamotrigine |
| Enrollment | 40 |
| Start date | Jan 1, 2002 |
| Completion | Jan 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 9, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: